The FBLN5 expression level in patients showed an increasing trend with an increase in tumor progression, lymph node metastasis, and pTNM stage, and the patient prognosis was poor, which suggests that FBLN5 might be a biomarker of tumor progression. Here, FBLN5 is linked to neoplasm.